[1]
|
Sung, H., Ferlay, J., Siegel, R.L., Laversanne, M., Soerjomataram, I., Jemal, A. and Bray, F. (2021) Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 71, 209-249. https://doi.org/10.3322/caac.21660
|
[2]
|
Ljungberg, B., Albiges, L., Abu-Ghanem, Y., Bedke, J., Capitanio, U., et al. (2022) European Association of Urology Guidelines on Renal Cell Carcinoma: The 2022 Update. European Urology, 82, 399-410. https://doi.org/10.1016/j.eururo.2022.03.006
|
[3]
|
Garje, R., Elhag, D., Yasin, H.A., Acharya, L., Vaena, D. and Dahmoush, L. (2021) Comprehensive Review of Chromophobe Renal Cell Carcinoma. Critical Reviews in Oncology/Hematology, 160, 103287. https://doi.org/10.1016/j.critrevonc.2021.103287
|
[4]
|
Capitanio, U. and Montorsi, F. (2016) Renal Cancer. Lancet, 387, 894-906. https://doi.org/10.1016/S0140-6736(15)00046-X
|
[5]
|
王伟玲, 吕明晓, 吉敬. 细胞周期调控蛋白作为抗肿瘤药物潜在靶标的研究进展[C]//南京康复医学会. 第二届全国康复与临床药学学术交流会议论文集(四). 2022: 400-404. https://doi.org/10.26914/c.cnkihy.2022.080892
|
[6]
|
Malumbres, M. and Barbacid, M. (2005) Mammalian Cyclin-Dependent Kinases. Trends in Biochemical Sciences, 30, 630-641. https://doi.org/10.1016/j.tibs.2005.09.005
|
[7]
|
Qian, D., Zheng, W., Chen, C., Jing, G. and Huang, J. (2020) Roles of CCNB2 and NKX3-1 in Nasopharyngeal Carcinoma. Cancer Biotherapy and Radiopharmaceuticals, 35, 208-213. https://doi.org/10.1089/cbr.2019.3016
|
[8]
|
Hoffmann, T.K., Trellakis, S., Okulicz, K., Schuler, P., Greve, J., Arnolds, J., et al. (2011) Cyclin B1 Expression and P53 Status in Squamous Cell Carcinomas of the Head and Neck. Anticancer Research, 31, 3151-3157.
|
[9]
|
Niemira, M., Collin, F., Szalkowska, A., Bielska, A., Chwialkowska, K., Reszec, J., Niklinski, J., Kwasniewski, M. and Kretowski, A. (2019) Molecular Signature of Subtypes of Non-Small-Cell Lung Cancer by Large-Scale Transcriptional Profiling: Identification of Key Modules and Genes by Weighted Gene Co-Expression Network Analysis (WGCNA). Cancers (Basel), 12, 37. https://doi.org/10.3390/cancers12010037
|
[10]
|
Aljohani, A.I., Toss, M.S., El-Sharawy, K.A., Mirza, S., Ball, G.R., Green, A.R., Rakha, E.A. (2022) Upregulation of Cyclin B2 (CCNB2) in Breast Cancer Contributes to the Development of Lymphovascular Invasion. American Journal of Cancer Research, 12, 469-489.
|
[11]
|
Yang, D., He, Y., Wu, B., Deng, Y., Wang, N., Li, M. and Liu, Y. (2020) Integrated Bioinformatics Analysis for the Screening of Hub Genes and Therapeutic Drugs in Ovarian Cancer. Journal of Ovarian Research, 13, Article No. 10. https://doi.org/10.1186/s13048-020-0613-2
|
[12]
|
Yin, S., Yang, S., Luo, Y., Lu, J., Hu, G., Wang, K., Shao, Y., Zhou, S., Koo, S., Qiu, Y., Wang, T. and Yu, H. (2021) Cyclin-Dependent Kinase 1 as a Potential Target for Lycorine against Hepatocellular Carcinoma. Biochemical Pharmacology, 193, 114806. https://doi.org/10.1016/j.bcp.2021.114806
|
[13]
|
Wu, F., Yang, J., Liu, J., Wang, Y., Mu, J., Zeng, Q., Deng, S. and Zhou, H. (2021) Signaling Pathways in Cancer-Associated Fibroblasts and Targeted Therapy for Cancer. Signal Transduction and Targeted Therapy, 6, Article No. 218. https://doi.org/10.1038/s41392-021-00641-0
|
[14]
|
Reina-Campos, M., Moscat, J. and Diaz-Meco, M. (2017) Metabolism Shapes the Tumor Microenvironment. Current Opinion in Cell Biology, 48, 47-53. https://doi.org/10.1016/j.ceb.2017.05.006
|
[15]
|
Gajewski, T.F., Schreiber, H. and Fu, Y.X. (2013) Innate and Adaptive Immune Cells in the Tumor Microenvironment. Nature Immunology, 14, 1014-1022. https://doi.org/10.1038/ni.2703
|
[16]
|
Zou, Y., Ruan, S., Jin, L., Chen, Z., Han, H., Zhang, Y., Jian, Z., Lin, Y., Shi, N. and Jin, H. (2020) CDK1, CCNB1, and CCNB2 Are Prognostic Biomarkers and Correlated with Immune Infiltration in Hepatocellular Carcinoma. Medical Science Monitor, 26, E925289. https://doi.org/10.12659/MSM.925289
|
[17]
|
Maier, E., Duschl, A. and Horejs-Hoeck, J. (2012) STAT6-Dependent and-Independent Mechanisms in Th2 Polarization. European Journal of Immunology, 42, 2827-2833. https://doi.org/10.1002/eji.201242433
|
[18]
|
Mantovani, A., Allavena, P., Sica, A. and Balkwill, F. (2008) Cancer-Related Inflammation. Nature, 454, 436-444. https://doi.org/10.1038/nature07205
|
[19]
|
Lee, H.L., Jang, J.W., Lee, S.W., Yoo, S.H., Kwon, J.H., Nam, S.W., Bae, S.H., Choi, J.Y., Han, N.I. and Yoon, S.K. (2019) Inflammatory Cytokines and Change of Th1/Th2 Balance as Prognostic Indicators for Hepatocellular Carcinoma in Patients Treated with Transarterial Chemoembolization. Scientific Reports, 9, Article No. 3260. https://doi.org/10.1038/s41598-019-40078-8
|
[20]
|
Budhu, A., Forgues, M., Ye, Q.H., Jia, H.L., He, P., Zanetti, K.A., et al. (2006) Prediction of Venous Metastases, Recurrence, and Prognosis in Hepatocellular Carcinoma Based on a Unique Immune Response Signature of the Liver Microenvironment. Cancer Cell, 10, 99-111. https://doi.org/10.1016/j.ccr.2006.06.016
|
[21]
|
Oh, D.Y. and Fong, L. (2021) Cytotoxic CD4 T Cells in Cancer: Expanding the Immune Effector Toolbox. Immunity, 54, 2701-2711. https://doi.org/10.1016/j.immuni.2021.11.015
|
[22]
|
Wculek, S.K., Cueto, F.J., Mujal, A.M., Melero, I., Krummel, M.F. and Sancho, D. (2020) Dendritic Cells in Cancer Immunology and Immunotherapy. Nature Reviews Immunology, 20, 7-24. https://doi.org/10.1038/s41577-019-0210-z
|
[23]
|
Xiao, Y., Ma, J., Guo, C., Liu, D., Pan, J. and Huang, X. (2022) Cyclin B2 Overexpression Promotes Tumour Growth by Regulating Jagged 1 in Hepatocellular Carcinoma. Aging, 14, 2855-2867. https://doi.org/10.18632/aging.203979
|